Document is current
Any future updates will be listed below
-
Authors
Canaud, Guillaume http://orcid.org/0000-0001-8146-7996
Hammill, Adrienne M.
Adams, Denise
Vikkula, Miikka
Keppler-Noreuil, Kim M.
- License Information
-
More Information
Article History
Received: 25 March 2021
Accepted: 27 June 2021
First Online: 8 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: G. Canaud: Personal fees from Novartis, Fresenius Medical Care, and BridgeBio; patent pending (WO2017140828A1). A. Hammill: Consultant and clinical trial contact for Novartis; clinical trial contact for ArQule/Merck and Venthera; compound received from Pfizer for investigator-initiated studies. D. Adams: Consultant to Novartis/Venthera. M. Vikkula: Consultant to Venthera. KMK-N: Investigator on clinical trial with Alpelisib.
